Table 3 Change in SE and AL progression between the first and second year and over 2-year atropine 0.01% treatment according to age.

From: Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression

Age group, years (N)

0–12 months

12–24 months

0–24 months

p-value*

 

SE (mean change ± SD, D)

 

 6–8 (23)

− 0.44 ± 0.52

− 0.47 ± 0.40

− 0.91 ± 0.75

0.648

 9–11 (41)

− 0.43 ± 0.36

− 0.48 ± 0.35

− 0.91 ± 0.53

 

 12–14 (17)

− 0.41 ± 0.36

− 0.34 ± 0.47

− 0.75 ± 0.56

 

AL (mean change ± SD, mm)

 

 6–8 (23)

0.31 ± 0.21

0.27 ± 0.16

0.59 ± 0.30

0.021

 9–11 (41)

0.25 ± 0.15

0.24 ± 0.13

0.49 ± 0.23

 

 12–14 (17)

0.19 ± 0.10

0.17 ± 0.13

0.36 ± 0.18

  1. N, patients; SE, spherical equivalent; SD, standard deviation; D, diopters; AL, axial length; SD, standard deviation.
  2. p value*: ANOVA test.
Back to article page